Drugs / GMCSF
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00973128 | Feb 2004 → Oct 2006 | cutaneous leishmaniasis | Hospital Universitário Professor Edgard Santos | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | GMCSF | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00973128 ↗ |
| Modality | Protein / enzyme biologic | “400 µg of recombinant human GM-CSF applied intralesionally” NCT00973128 ↗ |